glp 1 ibd 🚨 GLP-1 RA use in is rising fast In this 14-month repeated survey of patients with IBD: 📈 GLP-1 RA use rose 5-fold ⚖️ Median BMI fell from 35.3 → 31.2 Ever wondered how obesity, IBD,

Obesity and metabolic disorders are on the rise globally

Discover how GLP-1 medications like Wegovy and Zepbound reduce triglycerides, LDL cholesterol, and cardiovascular risk through proven metabolic effects beyond weight loss alone.

Clinically Studied for Metabolic Health: CQR-300 has been evaluated in 6 human clinical trials and shown to support reductions in calorie intake, body weight, and body fatwhile improving markers like blood sugar, cholesterol, and blood pressure

Supports strength, performance, recovery, and workout output

This approach is in line with guidelines and consensus statements from leading organizations, such as the American Diabetes Association, which advocate for integrated care in the management of diabetes and obesity, underscoring the significance of GLP-1 agonists in treating these interrelated conditions (American Diabetes Association, 2023)

Im trying to lose the 18 pounds I have gained since the pandemic